David G Standaert

David G Standaert i

University of Alabama Birmingham - Birmingham / United States
Medical and Health Sciences / Neurology
AD Scientific Index ID: 1702230
University of Alabama at Birmingham
person_outline David G Standaert's MOST POPULAR ARTICLES
1-) Levodopa and the progression of Parkinson\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s diseaseParkinson Study GroupNew England Journal of Medicine 351 (24), 2498-2508, 200420952004
2-) The Parkinson progression marker initiative (PPMI)K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ...Progress in neurobiology 95 (4), 629-635, 201111392011
3-) Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trialParkinson Study Group, Parkinson Study GroupJama 284 (15), 1931-1938, 200011162000
4-) Past, present, and future of Parkinson\'s disease: A special essay on the 200th Anniversary of the Shaking PalsyJA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ...Movement disorders 32 (9), 1264-1310, 20179392017
5-) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington\'s diseaseAW Dunah, H Jeong, A Griffin, YM Kim, DG Standaert, SM Hersch, ...Science 296 (5576), 2238-2243, 20028622002